Headline News

 

Adneuris Therapeutics grants Maruishi Pharmaceutical exclusive license to develop cebranopadol in Japan and South Korea

Posted on August 18, 2026

Johnson & Johnson introduces MONARCH QUEST 3, the next step forward in robotically assisted bronchoscopy

Posted on August 18, 2026

Thermo Fisher Scientific partners with The Michael J. Fox Foundation to advance proteomics driven precision medicine for Parkinson’s disease

Posted on August 18, 2026

Allergan Aesthetics updates Allergan Partner Privileges to better serve today’s modern aesthetics practices

Posted on August 18, 2026

Novo Nordisk and AWS form strategic partnership to speed up drug discovery using AI

Posted on August 18, 2026

Tagrisso combined with Orpathys shows statistically significant and clinically meaningful gains in progression free and overall survival for MET driven EGFR mutated lung cancer after progression on Tagrisso

Posted on August 18, 2026

AstraZeneca discontinues eVOLVE Lung02 Phase III trial of volrustomig plus chemotherapy in metastatic non small cell lung cancer

Posted on August 18, 2026

Enhertu shows statistically significant and clinically meaningful progression free survival benefit as first line treatment for HER2 mutant advanced non small cell lung cancer in DESTINY Lung04 Phase III trial

Posted on August 18, 2026

European Medicines Agency accepts review of Pfizer and Valneva’s Lyme disease vaccine application

Posted on August 18, 2026

FDA Clears Bristol Myers Squibb’s ZENBEXUS, the First CELMoD Drug, for Relapsed Multiple Myeloma Patients

Posted on August 18, 2026

Biogen completes acquisition of RayThera

Posted on August 10, 2026

Takeda’s ORZEYFUL cleared as the first and only medicine to address the root cause of narcolepsy type 1

Posted on August 10, 2026

Moderna kicks off Phase 1 clinical trial of mRNA-1469, its investigational vaccine targeting Bundibugyo ebolavirus

Posted on August 10, 2026

Moderna secures US FDA approval for its influenza vaccine mFLUSIVA

Posted on August 10, 2026

Novo Nordisk obtains a court order in the Netherlands blocking an unauthorised compounded semaglutide nasal spray from reaching patients

Posted on August 10, 2026